📰 Pooled Analysis News

Page 5 - Pooled Analysis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pooled Analysis. Real-time updates on events, politics, business and more.

Albireo Presents Data on Greater Efficacy in PFIC with Earlier Bylvay® Treatment at NASPGHAN

October 13, 2022

– New data presented at the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition meeting – Earlier treatment with Bylvay provided greater efficacy in... | October 13, 2022

United States United Kingdom Vastra Gotalands Lan Northern Ireland Mecklenburg Vorpommern Colleen Alabiso

Source: marketscreener.com

TAGRISSO® (osimertinib) demonstrated 5.5-year median disease-free survival in the adjuvant treatment of patients with EGFR-mutated lung cancer

September 11, 2022

Nearly three in four patients treated with adjuvant TAGRISSO were alive and disease-free at four years Exploratory results showed TAGRISSO also reduced the risk of disease recurrence in the brain or spinal cord by 76% in patients with Stage II-IIIA disease

United Kingdom Le Chevalier Provence Alpes Côd Azur United States France General Masahiro Tsuboi

Source: marketscreener.com

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Tagrisso approved in Japan for early lung cancer

August 25, 2022

Investegate announcements from AstraZeneca PLC, Tagrisso approved in Japan for early lung cancer

United States United Kingdom Dave Fredrickson Masahiro Tsuboi Daiichi Sankyo Thorac Onc

Source: investegate.co.uk

Data from Incyte's Dermatology Portfolio Accepted for Presentation at the 2022 European Academy of Dermatology and Venereology (EADV) Congress

August 24, 2022

Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its dermatology portfolio will be presented at the upcoming 2022 European Academy of Dermatology and Venereology (EADV)

United States Catalina Loveman Christine Chiou Hidradenitis Suppurativa Jim Lee European Academy Of Dermatology

Source: finanznachrichten.de

Data from Incyte's Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting

May 26, 2022

Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its oncology portfolio will be presented at the upcoming European Hematology Association 2022 (EHA2022) Congress (June

United States Hong Kong United Kingdom Ponatinib Iclusig Catalina Loveman Steven Stein

Source: finanznachrichten.de

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Investigational Adagrasib Delivers Positive Results in Registration-Enabling Study of Patients with KRASG12C-Mutated Advanced Non-Small Cell Lung Cancer

May 26, 2022

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced positive results from the...

United States Alexanderi Spira Charlesm Baum American Society Of Clinical Oncology Virginia Cancer Specialists Research Institute Prnewswire Mirati Therapeutics Inc

Source: prnewswire.com

Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022

May 18, 2022

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the...

San Diego United States New Jersey Lainie Keller Christina Cheng Research Posters

Source: prnewswire.com

Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine)

April 1, 2022

16 presentations will examine safety and efficacy of AJOVY and AUSTEDOTEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data for two of the company’s neurology portfolio treatments, AJOVY® (fr...

United States Yael Ashman Denisa Hurtukova A Survey Of Patients Drug Administration Teva Pharmaceuticals

Source: pharmiweb.com

HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS in Lung Cancer

March 7, 2022

07.03.2022 - HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 07, 2022 (GLOBE NEWSWIRE) - (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has received a US$15 million milestone payment from AstraZeneca PLC (“AstraZeneca”) ...

United States Hong Kong South Korea Mark Lee Zhou Yi Atholl Tweedie Freddy Crossley

Source: wallstreet-online.de